Clinical trial
Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
NCT02232308 is registered in ClinicalTrials.gov with Adil Bharucha as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects
- Lead sponsor
- Adil Bharucha
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- September 30, 2014
- Enrollment
- 24 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.